LBA24 Neoadjuvant immunotherapy in locally advanced MMR-deficient colon cancer: 3-year disease-free survival from NICHE-2

• DOI: 10.1016/j.annonc.2024.08.2263
• Publication Date: 2024-09-17T21:04:02Z
• Authors: M. Chalabi; L.D.W. van den Du...; Y.L. Verschoor; S. Balduzzi; P.G.M. de Gooyer; N. Kok; E. Kerver; C. Grootscholten; E.E. Voest; J.W.A. Burger; E.R. Hendriks; T.R. de Wijkerslooth; T. Tin; T.S. Aukema; S.J. Oosterling; A.G. Aalbers; J.G. van den Berg; M.E. van Leerdam; T.N. Schumacher; J.B.A.G. Haanen
• Keywords: Neoadjuvant Therapy